SUDDEN is an ambitious multidisciplinary research project that tackles the environmental hazards and sustainability challenges connected with drug design, production, consumption, and end-of-life. The overall objectives are to i) enhance the sustainability of drug discovery and development, ii) bridge the gaps in the legal framework of global production chains of pharmaceuticals, iii) redesign modern wastewater purification and recycling of sewage sludge, iv) develop circular economy models to pharmaceutical packaging materials, v) develop a Life Cycle Impact Assessment model for drug products, and vi) support sustainable economic growth in the pharmaceutical and cleantech sectors in Finland. The SUDDEN project addresses the scientifically most challenging domains of a drug’s life cycle: ‘benign-by-design’ drug discovery, preclinical characterization in terms of environmental risk assessment, manufacturing and consumption in terms of legal framework as well as the preferences and monetary valuations for environmentally-sound drug products, and end-of-life in terms of both molecular and packaging waste. We also focus on community engagement, ensuring that the key beneficiaries (authorities, industries, healthcare professionals) will be involved in the development of the science-based solutions through various interaction activities.

Sustainable drug discovery and development: SUDDEN Project

2019 Fall National Meeting

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.